The China Food and Drug Administration's Institute of Executive Development (CFDAIED) has signed an exclusive memorandum...
Roche recently announced that the China National Drug Administration (CNDA) has granted marketing authorization fo...
Adlai Nortye, a Hangzhou biopharma, has announced the opening of its first US site in Boston, Massachusetts. The Boston ...
HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small m...
A team of researchers led by Dr. Paddy Chan Kwok-leung of the Mechanical Engineering Department at the University of Hon...
China's leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited has announced ...
Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and d...
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines ...
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance ...
Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of thera...
Synergy Pharmaceuticals recently announced that the company has entered into a license agreement with Luoxin Pharm...
JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of ...
EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into ...
Australian and Chinese scientists have developed a method using coded nanoparticles to detect and help diagnose disease....
Ascletis Pharma Inc announced Ravidasvir is recommended by the World Health Organization (WHO) Guidelin...
On August 8, 2018, Beijing time I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biolog...
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater C...
